117 related articles for article (PubMed ID: 1389506)
1. Malignant melanoma treated with natural interferons alfa and beta and DAV.
Nagatani T; Ichiyama S; Miyakawa K; Uchiyama M
Eur J Cancer; 1992; 28A(10):1774. PubMed ID: 1389506
[No Abstract] [Full Text] [Related]
2. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival.
Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T
Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724
[No Abstract] [Full Text] [Related]
3. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma.
Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H
Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034
[No Abstract] [Full Text] [Related]
4. A phase II study of metastatic melanoma treated with a combination of interferon alfa 2b, dacarbazine and nimustine.
Gröhn P; Kumpulainen E; Nuortio L; Hakala T; Vuoristo MS; Korpela M; Heikkinen M; Salmi R; Jakobsson M; Numminen S
Eur J Cancer; 1992; 28(2-3):441-3. PubMed ID: 1591060
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of malignant melanoma].
Ishihara K
Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980
[TBL] [Abstract][Full Text] [Related]
6. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma.
Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K
J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342
[TBL] [Abstract][Full Text] [Related]
7. Statistical survey from 1982 to 1991 of 49 patients with malignant melanocytic tumors.
Ueda E; Kishimoto S; Yasuno H
J Dermatol; 1995 Jul; 22(7):467-74. PubMed ID: 7560435
[TBL] [Abstract][Full Text] [Related]
8. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon.
Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R
J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215
[No Abstract] [Full Text] [Related]
9. Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma.
Nitta Y; Ikeya T; Sakakibara A; Tomita Y
J Dermatol; 2011 Feb; 38(2):164-8. PubMed ID: 21269313
[TBL] [Abstract][Full Text] [Related]
10. [Primary intracranial melanoma: a case report].
Takano S; Saito M; Murata K; Ohbu M; Miyasaka Y; Yada K; Kan S; Takagi H
No Shinkei Geka; 1992 Nov; 20(11):1211-5. PubMed ID: 1448198
[TBL] [Abstract][Full Text] [Related]
11. [Case of primary amelanotic malignant melanoma of the female urethra].
Yoshii T; Horiguchi A; Shirotake S; Tobe M; Tasaki S; Hayakawa M; Sumitomo M; Asano T
Nihon Hinyokika Gakkai Zasshi; 2010 Sep; 101(6):734-7. PubMed ID: 20954381
[TBL] [Abstract][Full Text] [Related]
12. [Metastatic malignant melanoma of the urinary bladder: a case report].
Nohara T; Sakai A; Fuse H; Imamura Y
Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):707-11. PubMed ID: 19999137
[TBL] [Abstract][Full Text] [Related]
13. Dacarbazine, vincristine, bleomycin and lomustine plus natural interferon-alpha for metastatic melanoma.
Reinhold U; Bruske T; Kreysel HW
Eur J Cancer; 1996 Jan; 32A(1):180. PubMed ID: 8695233
[No Abstract] [Full Text] [Related]
14. [Chemotherapy of malignant melanoma].
Ishihara K; Yamazaki N; Asano K
Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498
[TBL] [Abstract][Full Text] [Related]
15. [Combined treatment with dacarbazine, nimustine, cisplatin, and tamoxifen plus interferon-beta in a patient with advanced anorectal malignant melanoma].
Kawano N; Tashiro M; Taguchi M; Kihara Y; Yoshikawa I; Syukuwa K; Yamasaki M; Kume K; Otsuki M
Nihon Shokakibyo Gakkai Zasshi; 2008 Nov; 105(11):1627-33. PubMed ID: 18987448
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant chemotherapy of malignant melanoma of the female genital organs].
Inoue S; Shibata S; Tohya T; Munemura M; Fujisaki S; Maeyama M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):135-8. PubMed ID: 3456398
[No Abstract] [Full Text] [Related]
17. [A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy].
Sasaki S; Kojima T; Hidemura A; Hatanaka K; Uekusa T; Ishimaru M
Gan To Kagaku Ryoho; 2010 Oct; 37(10):1999-2002. PubMed ID: 20948273
[TBL] [Abstract][Full Text] [Related]
18. [Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy].
Jimbow K; Takahashi H; Ishihara K; Hayasaka K; Kukita A; Seki Y; Ikeda S; Terakado T
Gan To Kagaku Ryoho; 1982 Nov; 9(11):1942-9. PubMed ID: 7184382
[TBL] [Abstract][Full Text] [Related]
19. Primary malignant melanoma of the esophagus treated by esophagectomy and systemic chemotherapy.
Matsutani T; Onda M; Miyashita M; Hagiwara N; Akiya Y; Takubo K; Yamashita K; Sasajima K
Dis Esophagus; 2001; 14(3-4):241-4. PubMed ID: 11869329
[TBL] [Abstract][Full Text] [Related]
20. Complete remission of metastatic clear cell sarcoma with DAV chemotherapy.
Fujimoto M; Hiraga M; Kiyosawa T; Murakami T; Murata S; Ohtsuki M; Nakagawa H
Clin Exp Dermatol; 2003 Jan; 28(1):22-4. PubMed ID: 12558622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
